The activation of PGC-1α and its downstream targets, including mitochondrial transcription factor 1 (TFAM) and nuclear respiratory factor 1 (NRF1), have been shown to reduce renal injury in DKD by improving mitochondrial function and reducing ROS levels [14]. This evidence concerns the gene PPARGC1A and diabetic kidney disease.